Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

A cell-based subretinal implant shows promise in the treatment of geographic atrophy, achieving the unprecedented milestone ...

Many novel treatment approaches are being investigated to halt progression of geographic atrophy (GA ... intravitreal gene therapies and cell-based therapies. However, other approaches broadly ...

Geographic atrophy is an advanced form of dry age-related ... and studying whether modified vitamin A could protect retinal cells. Can artificial intelligence help people who have GA?

Little is known about meibomian gland progenitor cells; however, repeated exposure to environmental stress, such as contact lens wear or ocular surface drying, may lead to a similar phenomenon to ...

Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy ...

Alongside NeuroNata-R, CORESTEM is also progressing the clinical development of stem cell therapies for lupus nephritis and multiple system atrophy (both phase 1) and a pipeline of preclinical ...

a Bangalore-based cell therapy company, is pleased to announce significant vision improvement in Phase 1 trials of its investigational drug, Eyecyte-RPE™, in patients with geographic atrophy (GA ...